Women on the Pill Have Comforting CVD Outcomes Years Down the Line
(MedPage Today) -- Reassuringly, a history of oral contraceptive use had no deleterious effects on cardiovascular disease (CVD) and survival over long-term follow-up, a U.K. Biobank study showed.
In a comparison between women who have used the... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - August 11, 2023 Category: Urology & Nephrology Source Type: news
COVID Cleared of Increasing Risk of Type 1 Diabetes in Kids?
(MedPage Today) -- COVID-19 infection didn't appear to precipitate a diagnosis of type 1 diabetes in kids, a prospective multinational cohort study suggested.
Researchers tested more than 4,500 adolescents every few months for type 1 diabetes... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - August 2, 2023 Category: Urology & Nephrology Source Type: news
Aspartame Is a 'Possible' Carcinogen, WHO Declares
(MedPage Today) -- The WHO has declared aspartame, a food additive used frequently in diet soda and other low-calorie beverages, "possibly" carcinogenic to humans, but did not make any changes to its recommendations for maximum daily aspartame... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - July 13, 2023 Category: Urology & Nephrology Source Type: news
ARNI Again Shows Modest Benefits in HF With Mid-Range EF
(MedPage Today) -- Starting sacubitril/valsartan (Entresto) for recently decompensated heart failure with ejection fraction (EF) over 40% improved a key prognostic marker and, for those in the 40-60% range, clinical outcomes as well, the PARAGLIDE... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - June 23, 2023 Category: Urology & Nephrology Source Type: news
Hemodiafiltration Reduced Dialysis Mortality in Kidney Failure
(MedPage Today) -- High-dose hemodiafiltration improved survival compared with standard hemodialysis for patients with kidney failure resulting in the need for kidney-replacement therapy, according to the randomized CONVINCE trial.
High-dose hemodiafiltration... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - June 17, 2023 Category: Urology & Nephrology Source Type: news
Cystic Renal Masses Often Harbor High-Grade Disease
(MedPage Today) -- Almost a fourth of renal cysts had pathologically high-grade disease, which did not have a correlation with growth rate or increase the risk with active surveillance (AS), according to a large retrospective review.
Overall... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - June 16, 2023 Category: Urology & Nephrology Source Type: news
Here's the Hydration Advice You Can Ignore
(MedPage Today) -- Drink eight 8-ounce glasses of water each day. Strive for very light yellow urine.
The messaging around proper hydration can be daunting -- but is it necessary?
Nephrologists and neuroscientists who study thirst and hydration... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - June 13, 2023 Category: Urology & Nephrology Source Type: news
MitraClip Shines in Real-World, Core-Lab Data
(MedPage Today) -- PHOENIX -- Newer MitraClip devices reduced mitral regurgitation (MR) to no more than a trace for nearly all patients, regardless of anatomical complexity or presence of advanced heart failure, in a pooled analysis that combined... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - June 9, 2023 Category: Urology & Nephrology Source Type: news
Treating Early Hospitalization Blood Pressure Deemed a No-No for Patient Safety
(MedPage Today) -- For older people hospitalized with noncardiovascular diagnoses, intensive lowering of asymptomatic inpatient blood pressures (BPs) may constitute overtreatment and lead to harm, observational data suggested.
U.S. veterans acutely... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - May 31, 2023 Category: Urology & Nephrology Source Type: news
Monoclonal Antibody Reduced Need For Transfusions in Low-Risk MDS
(MedPage Today) -- CHICAGO -- Patients with transfusion-dependent, low-risk myelodysplastic syndromes (MDS) needed significantly fewer transfusions when treated with luspatercept (Reblozyl) for anemia compared with the current standard of care... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - May 25, 2023 Category: Urology & Nephrology Source Type: news
Brain Bleed Outcomes Improve With Bundled Care Strategy
(MedPage Today) -- Bundling early blood pressure (BP) lowering with other simple medical interventions produced clinical benefits in acute intracerebral hemorrhage (ICH), according to the large INTERACT3 trial conducted in lower income countries... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - May 25, 2023 Category: Urology & Nephrology Source Type: news
HF Shunt Results Hold Up Midterm in Early Data
(MedPage Today) -- PHOENIX -- The functional and quality-of-life benefits of creating a left-to-right shunt in the interatrial septum to offload failing hearts held up over the midterm in a series of small feasibility studies.
Across the ALLEVIATE... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - May 19, 2023 Category: Urology & Nephrology Source Type: news
Lower BP Might Mean Less Cardiac Conduction Disease
(MedPage Today) -- Left ventricular (LV) conduction disease might have been prevented with aggressive blood pressure (BP) control, a post hoc analysis of SPRINT showed.
Individuals randomized to the intensive systolic BP target of <120 mm Hg... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - May 3, 2023 Category: Urology & Nephrology Source Type: news
Common Diuretic Pauses Atherosclerosis in CKD, T2D
(MedPage Today) -- AUSTIN, Texas -- The diuretic spironolactone stopped the progression of atherosclerosis in people with type 2 diabetes and chronic kidney disease (CKD), according to the MAGMA trial.
Among 79 patients with stages 3 to 4 CKD... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - April 15, 2023 Category: Urology & Nephrology Source Type: news
Do All Those Postmarket Device Modifications Add Up to Patient Harm?
(MedPage Today) -- The more modifications allowed to high-risk medical devices on the market, the more there are subsequent device recalls, according to a study shining a light on premarket approval (PMA) supplements and patient safety.
An FDA... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - April 12, 2023 Category: Urology & Nephrology Source Type: news
